Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials

被引:0
作者
Krithika Rajagopalan
Elizabeth Dansie Bacci
Daisy Ng-Mak
Kathy Wyrwich
Andrei Pikalov
Antony Loebel
机构
[1] Sunovion Pharmaceuticals Inc.,
[2] Evidera,undefined
[3] Evidera,undefined
来源
BMC Psychiatry | / 16卷
关键词
Quality of life enjoyment and satisfaction questionnaire; Patient functioning; Bipolar disorder; Depression; Drug therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 172 条
  • [1] Merikangas KR(2007)Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Archives of general psychiatry 64 543-52
  • [2] Akiskal HS(2011)Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative Archives of general psychiatry 68 241-51
  • [3] Angst J(2008)Burden of bipolar depression: impact of disorder and medications on quality of life CNS drugs 22 389-406
  • [4] Greenberg PE(2015)Diagnosis, epidemiology and management of mixed states in bipolar disorder CNS drugs 29 725-40
  • [5] Hirschfeld RM(2010)Functional impairment and disability across mood states in bipolar disorder Value in health 13 984-8
  • [6] Petukhova M(2007)Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia Bipolar Disord 9 114-25
  • [7] Merikangas KR(2014)The prevalence and burden of bipolar depression J Affect Disord 169 S3-11
  • [8] Jin R(2012)Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions Bipolar Disord 14 271-82
  • [9] He JP(2015)Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder J Clin Psychiatry 76 e809-14
  • [10] Kessler RC(1979)A new depression scale designed to be sensitive to change Br J Psychiatry 134 382-9